title: Autologous heart cell transplantation improves cardiac function after myocardial injury.
abstract: BACKGROUND
  Fetal ventricular cardiomyocyte transplantation into a cardiac scar improved ventricular function, but these cells were eventually eliminated by rejection. We therefore examined the feasibility of autologous adult heart cell transplantation.
  
  
  METHODS
  A transmural scar was produced in the left ventricular free wall of adult rats by cryoinjury. The left atrial appendage was harvested, and the atrial heart cells were cultured and their number expanded ex vivo. Three weeks after cryoinjury, either a cell suspension (2 x 10(6) cells, n = 12 rats, transplant group) or culture medium (n = 10 rats, control group) was injected into the scar. Rats having a sham operation (n = 5) did not undergo cryoinjury or transplantation with cells or culture medium.
  
  
  RESULTS
  Five weeks after injection, ventricular function was evaluated in a Langendorff preparation, measuring systolic, diastolic, and developed pressures over a range of intraventricular balloon volumes. Systolic and developed pressures were greater in the transplant group than in the control group (p = 0.0001). Rats with a sham operation had the greatest systolic, diastolic, and developed pressures (p = 0.0001). Histologic studies demonstrated survival of the transplanted heart cells within the scar. The area of the scar was smaller (p = 0.0003) and its thickness greater (p = 0.0003) in rats in the transplant group. Left ventricular chamber volume was smaller in the transplant group (p = 0.043).
  
  
  CONCLUSIONS
  Transplantation of autologous cultured adult atrial heart cells limited scar thinning and dilatation and improved myocardial function compared with results in control hearts. This technique may lead to a novel therapy to prevent scar expansion after a myocardial infarction and prevent the development of congestive heart failure.
authors.affiliation: Department of Surgery, The Toronto Hospital, University of Toronto, Ontario, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Sakai
authors.forename: R K
authors.initials: RK
authors.lastname: Li
authors.forename: R D
authors.initials: RD
authors.lastname: Weisel
authors.forename: D A
authors.initials: DA
authors.lastname: Mickle
authors.forename: E J
authors.initials: EJ
authors.lastname: Kim
authors.forename: S
authors.initials: S
authors.lastname: Tomita
authors.forename: Z Q
authors.initials: ZQ
authors.lastname: Jia
authors.forename: T M
authors.initials: TM
authors.lastname: Yau
mesh_terms: D000818:Animals; D017690:Cell Transplantation; D002478:Cells, Cultured; D006325:Heart Atria; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction; D009206:Myocardium / Q000166:cytology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014182:Transplantation, Autologous; D016276:Ventricular Function; D016277:Ventricular Function, Left; D017725:Ventricular Pressure; D020257:Ventricular Remodeling